A regulatory feedback loop between Ca2+/calmodulin-dependent protein kinase kinase 2 (CaMKK2) and the androgen receptor in prostate cancer progression

Journal of Biological Chemistry

Volumn 287, Issue 29, 2012, Pages 24832-24843

  Karacosta, Loukia G ^a   Foster, Barbara A ^b   Azabdaftari, Gissou ^b   Feliciano, David M ^a   Edelman, Arthur M ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTORS; ANDROGEN-DEPENDENT; CELL CYCLE; CELL CYCLE CONTROL; CELL LINES; CYCLIND1; DIHYDROTESTOSTERONE; FEED-BACK LOOP; GENE PROMOTER; HYPERPHOSPHORYLATED; LNCAP CELLS; MOLECULAR MECHANISM; PROSTATE CANCERS; PROSTATE SPECIFIC ANTIGEN; PROTEIN EXPRESSIONS; PROTEIN KINASE; PROTEIN LEVEL; REGULATORY FEEDBACK LOOPS; S-PHASE; TRANSCRIPTIONAL ACTIVITY; TRANSGENICS; TUMOR XENOGRAFTS; TUMORIGENIC CELLS;

CALMODULIN; CELL CULTURE; CELL PROLIFERATION; CELLS; DISEASES; ENZYMES; RUBIDIUM; UROLOGY;

GENE EXPRESSION;

ANDROGEN RECEPTOR; ANDROSTANOLONE; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE KINASE; CELL CYCLE PROTEIN; CYCLIN D1; MESSENGER RNA; PROBASIN; PROSTATE SPECIFIC ANTIGEN; PROTEIN CAMKK2; RETINOBLASTOMA PROTEIN; UNCLASSIFIED DRUG;

ADVANCED CANCER; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CELL CYCLE G1 PHASE; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL NUCLEUS; CELL PROLIFERATION; CELL STRAIN LNCAP; CONTROLLED STUDY; FEEDBACK SYSTEM; GENE TARGETING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE ADENOCARCINOMA; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; RNA INTERFERENCE; TRANSCRIPTION INITIATION; TRANSGENIC MOUSE; TUMOR XENOGRAFT;

ANIMALS; BLOTTING, WESTERN; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE KINASE; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE;

EID: 84863799823     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.370783     Document Type: Article

References (57)

1. 2+/CaMdependent protein kinase cascade in health and disease. Subcell. Biochem. 45, 169-214
2. 2+/calmodulin-dependent protein kinase cascade. J. Biol. Chem. 270, 19320-19324
3. 2+/calmodulin-dependent protein kinase kinases from rat brain. J. Biol. Chem. 271, 10806-10910
4. 2+/calmodulin-dependent protein kinase kinase β. J. Biochem. 122, 243-250
5. Anderson, K. A., Means, R. L., Huang, Q. H., Kemp, B. E., Goldstein, E. G., Selbert, M. A., Edelman, A. M., Fremeau, R. T., and Means, A. R. (1998) Components of a calmodulin-dependent protein kinase cascade, molecular cloning, functional characterization and cellular localization of Ca2+/calmodulin- dependent protein kinase kinase β. J. Biol. Chem. 273, 31880-31889 (Pubitemid 29177125)
6. Haribabu, B., Hook, S. S., Selbert, M. A., Goldstein, E. G., Tomhave, E. D., Edelman, A. M., Snyderman, R., and Means, A. R. (1995) Human calciumcalmodulin-dependent protein kinase I, cDNA cloning, domain structure and activation by phosphorylation at threonine 177 by calcium-calmodulin-dependent protein kinase I kinase. EMBO J. 14, 3679-3686
7. 2+- calmodulin-dependent protein kinase Ia kinase. Phosphorylation of threonine 196 is essential for activation. J. Biol. Chem. 270, 17616-17621
8. Yano, S., Tokumitsu, H., and Soderling, T. R. (1998) Calcium promotes cell survival through CaM-K kinase activation of the protein kinase-B pathway. Nature 396, 584-587 (Pubitemid 28563720)
9. Hawley, S. A., Pan, D. A., Mustard, K. J., Ross, L., Bain, J., Edelman, A. M., Frenguelli, B. G., and Hardie, D. G. (2005) Calmodulin-dependent protein kinase kinase-β is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab. 2, 9-19 (Pubitemid 43239821)
10. 2+/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases. J. Biol. Chem. 280, 29060-29066
11. 2+/ calmodulin-dependent protein kinase kinase-β acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab. 2, 21-33
12. Hardie, D. G. (2007) AMP-activated/SNF1 protein kinases, conserved guardians of cellular energy. Nat. Rev. Mol. Cell Biol. 8, 774-785
13. Wayman, G. A., Lee, Y. S., Tokumitsu, H., Silva, A. J., and Soderling, T. R. (2008) Calmodulin kinases, modulators of neuronal development and plasticity. Neuron 59, 914-931
14. Park, I. K., and Soderling, T. R. (1995) Activation of Ca/calmodulin-dependent protein kinase (CaM-kinase) IV by CaM-kinase kinase in Jurkat T lymphocytes. J. Biol. Chem. 270, 30464-30469
15. Aletta, J. M., Selbert, M. A., Nairn, A. C., and Edelman, A. M. (1996) Activation of a calcium-calmodulin-dependent protein kinase I cascade in PC12 cells. J. Biol. Chem. 271, 20930-20934 (Pubitemid 26281883)
16. 2+/calmodulin-dependent protein kinase kinase β by autophosphorylation. Biochemistry 50, 8193-8201
17. 2+/calmodulin-dependent protein kinase kinase β is regulated by multisite phosphorylation. J. Biol. Chem. 286, 28066-28079
18. Green, M. F., Anderson, K. A., and Means, A. R (2011) Characterization of the CaMKKβ-AMPK signaling complex. Cell. Signal. 23, 2005-2012
19. Dhanasekaran, S. M., Barrette, T. R., Ghosh, D., Shah, R., Varambally, S., Kurachi, K., Pienta, K. J., Rubin, M. A., and Chinnaiyan, A. M. (2001) Delineation of prognostic biomarkers in prostate cancer. Nature 412, 822-826 (Pubitemid 32801464)
20. Welsh, J. B., Sapinoso, L. M., Su, A. I., Kern, S. G., Wang-Rodriguez, J., Moskaluk, C. A., Frierson, H. F., Jr., and Hampton, G. M. (2001) Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer. Cancer Res. 61,5974-5978 (Pubitemid 32762523)
21. Ernst, T., Hergenhahn, M., Kenzelmann, M., Cohen, C. D., Bonrouhi, M., Weninger, A., Klären, R., Gröne, E. F., Wiesel, M., Güdemann, C., Küster, J., Schott, W., Staehler, G., Kretzler, M., Hollstein, M., and Gröne, H. J. (2002) Decrease and gain of gene expression are equally disciminatory markers for prostate carcinoma. Am. J. Pathol. 160, 2169-2180
22. Ashida, S., Nakagawa, H., Katagiri, T., Furihata, M., Iiizumi, M., Anazawa, Y., Tsunoda, T., Takata, R., Kasahara, K., Miki, T., Fujioka, T., Shuin, T., and Nakamura, Y. (2004) Molecular features of the transition from prostatic intraepithelial neoplasia (PIN) to prostate cancer, genome-wide gene expression profiles of prostate cancers and PINs. Cancer Res. 64, 5963-5972 (Pubitemid 39129392)
23. Lapointe, J., Li, C., Higgins, J. P., van de Rijn, M., Bair, E., Montgomery, K., Ferrari, M., Egevad, L., Rayford, W., Bergerheim, U., Ekman, P., DeMarzo, A. M., Tibshirani, R., Botstein, D., Brown, P. O., Brooks, J. D., and Pollack, J. R. (2004) Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Proc. Natl. Acad. Sci. U.S.A. 101, 811-816 (Pubitemid 38121040)
24. Yu, Y. P., Landsittel, D., Jing, L., Nelson, J., Ren, B., Liu, L., McDonald, C., Thomas, R., Dhir, R., Finkelstein, S., Michalopoulos, G., Becich M., and Luo, J. H. (2004) Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy. J. Clin. Oncol. 22, 2790-2799 (Pubitemid 41079896)
25. Kristiansen, G., Pilarsky, C., Wissmann, C., Kaiser, S., Bruemmendorf, T., Roepcke, S., Dahl, E., Hinzmann, B., Specht, T., Pervan, J., Stephan, C., Loening, S., Dietel, M., and Rosenthal, A. (2005) Expression profiling of microdissected matched prostate cancer samples reveals CD166/MEMD and CD24 as new prognostic markers for patient survival. J. Pathol. 205, 359-376 (Pubitemid 40253926)
26. Lozano, J. J., Soler, M., Bermudo, R., Abia, D., Fernandez, P. L., Thomson, T. M., and Ortiz, A. R. (2005) Dual activation of pathways regulated by steroid receptors and peptide growth factors in primary prostate cancer revealed by factor analysis of microarray data. BMC Genomics 2005, 6, 109, doi:10.1186/1471-2164-6
27. Varambally, S., Yu, J., Laxman, B., Rhodes, D. R., Mehra, R., Tomlins, S. A., Shah, R. B., Chandran, U., Monzon, F. A., Becich, M. J., Wei, J. T., Pienta, K. J., Ghosh, D., Rubin, M. A., and Chinnaiyan, A. M. (2005) Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression. Cancer Cell 8, 393-406 (Pubitemid 41579834)
28. Hendriksen, P. J., Dits, N. F., Kokame, K., Veldhoven, A., van Weerden, W. M., Bangma, C. H., Trapman, J., and Jenster, G. (2006) Evolution of the androgen receptor pathway during progression of prostate cancer. Cancer Res. 66, 5012-5020 (Pubitemid 43844921)
29. True, L., Coleman, I., Hawley, S., Huang, C. Y., Gifford, D., Coleman, R., Beer, T. M., Gelmann, E., Datta, M., Mostaghel, E., Knudsen, B., Lange, P., Vessella, R., Lin, D., Hood, L., and Nelson, P. S. (2006) A molecular correlate to the Gleason grading system for prostate adenocarcinoma. Proc. Natl. Acad. Sci. U.S.A. 103, 10991-10996 (Pubitemid 44148406)
30. Tomlins, S. A., and Chinnaiyan, A. M. (2007) in Prostate Cancer (Chung, L. W. K., Isaacs, W. B., and Simons, J. W., eds) pp. 247-267, Humana Press, Clifton, NJ
31. Massie, C. E., Lynch, A., Ramos-Montoya, A., Boren, J., Stark, R., Fazli, L., Warren, A., Scott, H., Madhu, B., Sharma, N., Bon, H., Zecchini, V., Smith, D. M., Denicola, G. M., Mathews, N., Osborne, M., Hadfield, J., Macarthur, S., Adryan, B., Lyons, S. K., Brindle, K. M., Griffiths, J., Gleave, M. E., Rennie, P. S., Neal, D. E., and Mills, I. G. (2011) The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis. EMBO J. 30, 2719-2733
32. Nelson, P. S., Clegg, N., Arnold, H., Ferguson, C., Bonham, M., White, J., Hood, L., and Lin, B. (2002) The program of androgen-responsive genes in neoplastic prostatic epithelium. Proc. Natl. Acad. Sci. U.S.A. 99, 11890-11895 (Pubitemid 34994494)
33. Frigo, D. E., Howe, M. K., Wittmann, B. M., Brunner, A. M., Cushman, I., Wang, Q., Brown, M., Means, A. R., and McDonnell, D. P. (2011) CaM kinase kinase β-mediated activation of the growth regulatory kinase AMPK is required for androgen-dependent migration of prostate cancer cells. Cancer Res. 71,528-537
34. Mendiratta, P., Mostaghel, E., Guinney, J., Tewari, A. K., Porrello, A., Barry, W. T., Nelson, P. S., and Febbo, P.G. (2009) Genomic strategy for targeting therapy in castration-resistant prostate cancer. J. Clin. Oncol. 27, 2022-2029
35. Bluemn, E. G., and Nelson, P. S. (2012) The androgen/androgen receptor axis in prostate cancer. Curr. Opin. Oncol. 24, 251-257
36. Sedelaar, J. P., and Isaacs, J. T. (2009) Tissue culture media supplemented with 10% fetal calf serum contains a castrate level of testosterone. The Prostate 69, 1724-1729
37. 2+/calmodulin-dependent protein kinase IV signaling accelerates retinoic acid-induced dfferentiation of human neuroblastoma cells. J. Biol. Chem. 284, 26466-26481
38. Gregory, C. W., Johnson, R. T., Jr., Mohler, J. L., French, F. S., and Wilson, E. M. (2001) Androgen receptor stabilization in recurrent prostate cancer is associated with hypersensitivity to low androgen. Cancer Res. 61, 2892-2898 (Pubitemid 32691931)
39. Gingrich, J. R., Barrios, R. J., Foster, B. A., and Greenberg, N. M. (1999) Pathologic progression of autochthonous prostate cancer in the TRAMP model. Prostate Cancer Prostatic Dis. 2, 70-75 (Pubitemid 29259935)
40. Nagabhushan, M., Miller, C. M., Pretlow, T. P., Giaconia, J. M., Edgehouse, N. L., Schwartz, S., Kung, H. J., de Vere White, R. W., Gumerlock, P. H., Resnick, M. I., Amini, S. B., and Pretlow, T. G. (1996) CWR22, the first human prostate cancer xenograft with strongly androgen-dependent and relapsed strains both in vivo and in soft agar. Cancer Res. 56, 3042-3046
41. Snoek, R., Cheng, H., Margiotti, K., Wafa, L. A., Wong, C. A., Wong, E. C., Fazli, L., Nelson, C. C., Gleave, M. E., and Rennie, P. S. (2009) In vivo knockdown of the androgen receptor results in growth inhibition and regression of well established, castration-resistant prostate tumors. Clin. Cancer Res. 15, 39-47
42. Tilley, W. D., Wilson, C. M., Marcelli, M., and McPhaul, M. J. (1990) Androgen receptor gene expression in human prostate carcinoma cell lines. Cancer Res. 50, 5382-5386 (Pubitemid 20302992)
43. Tararova, N. D., Narizhneva, N., Krivokrisenko, V., Gudkov, A. V., and Gurova, K. V. (2007) Prostate cancer cells tolerate a narrow range of androgen receptor expression and activity. Prostate 67, 1801-1815 (Pubitemid 350228732)
44. Wang, Q., Carroll, J. S., and Brown, M. (2005) Spatial and temporal recruitment of androgen receptor and its coactivators involves chromosomal looping and polymerase tracking. Mol. Cell 19, 631-642 (Pubitemid 41219439)
45. Balk, S. P. and Knudson, K. E. (2008) AR, the cell cycle, and prostate cancer. Nucl. Recept. Signal. 6, 1-12
46. Schiewer, M. J., Augello, M. A., and Knudsen, K. E. (2012) The AR-dependent cell cycle, mechanisms and cancer relevance. Mol. Cell Endocrinol. 352, 34-45
47. Xu, Y., Chen, S. Y., Ross, K. N., and Balk, S. P. (2006) Androgens induce prostate cancer cell proliferation through mammalian target of rapamycin activation and post-transcriptional increases in cyclin D proteins. Cancer Res. 66, 7783-7792 (Pubitemid 44289239)
48. Kahl, C. R., and Means, A. R. (2004) Regulation of cyclin D1/CDK4 complexes by calcium/calmodulin-dependent protein kinase I. J. Biol. Chem. 279, 15411-15419 (Pubitemid 38618940)
49. Rodriguez-Mora, O. G., LaHair, M. M., McCubrey, J. A., and Franklin, R. A. (2005) Calcium/calmodulin-dependent kinase I and calcium/calmodulin-dependent kinase kinase participate in the control of cell cycle progression in MCF-7 human breast cancer cells. Cancer Res. 65, 5408-5416 (Pubitemid 40827354)
50. Schmitt, J. M., Abell, E., Wagner, A., and Davare, M. A. (2010) ERK activation and cell growth require CaM kinases in MCF-7 breast cancer cells. Mol. Cell. Biochem. 335, 155-171
51. Gioeli, D., and Paschal, B. M. (2012) Post-translational modification of the androgen receptor. Mol. Cell. Endocrinol. 352, 70-78
52. Cifuentes, E., Mataraza, J. M., Yoshida, B. A., Menon, M., Sacks, D. B., Barrack, E. R., and Reddy, G. P. (2004) Physical and functional interaction of androgen receptor with calmodulin in prostate cancer cells. Proc. Natl. Acad. Sci. U.S.A. 101, 464-469 (Pubitemid 38084659)
53. 2+/ calmodulin-dependent protein kinase kinase. J. Biol. Chem. 277, 15813-15818
54. Yang, C. S., Xin, H. W., Kelley, J. B., Spencer, A., Brautigan, D. L., and Paschal, B. M. (2007) Ligand binding to the androgen receptor induces conformational changes that regulate phosphatase interactions. Mol. Cell. Biol. 27, 3390-3404 (Pubitemid 46685215)
55. Boynton, A. L., Whitfield, J. F., Isaacs, R. J., and Tremblay, R. G. (1977) Different extracellular calcium requirements for proliferation of nonneoplastic, preneoplastic, and neoplastic mouse cells. Cancer Res. 37, 2657-2661
56. Liao, J., Schneider, A., Datta, N. S., and McCauley, L. K. (2006) Extracellular calcium as a candidate mediator of prostate cancer skeletal metastasis. Cancer Res. 66, 9065-9073 (Pubitemid 44521125)
57. Steinsapir, J., Socci, R., and Reinach, P. (1991) Effects of androgen on intracellular calcium of LNCaP cells. Biochem. Biophys. Res. Commun. 179, 90-96